Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data
about
A methodological review of models used to estimate the cost effectiveness of antiretroviral regimens for the treatment of HIV infection.Should we be testing for baseline integrase resistance in patients newly diagnosed with HIV?Lopinavir/ritonavir versus darunavir plus ritonavir for HIV infection: a cost-effectiveness analysis for the United States.
P2860
Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Economic modeling of the combi ...... based on ACTG 5142 trial data
@ast
Economic modeling of the combi ...... based on ACTG 5142 trial data
@en
type
label
Economic modeling of the combi ...... based on ACTG 5142 trial data
@ast
Economic modeling of the combi ...... based on ACTG 5142 trial data
@en
prefLabel
Economic modeling of the combi ...... based on ACTG 5142 trial data
@ast
Economic modeling of the combi ...... based on ACTG 5142 trial data
@en
P2093
P2860
P356
P1476
Economic modeling of the combi ...... based on ACTG 5142 trial data
@en
P2093
Birgitta Dietz
Kevin W Garren
Kit N Simpson
Menaka Bhor
Richard H Haubrich
Robert W Baran
Sharon A Riddler
P2860
P2888
P356
10.1186/1478-7547-9-5
P577
2011-05-08T00:00:00Z
P5875
P6179
1016857468